Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Anthelmintics
1.2.3 Antiprotozoals
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antiparasitic Drugs Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiparasitic Drugs Market Perspective (2018-2034)
2.2 Antiparasitic Drugs Growth Trends by Region
2.2.1 Global Antiparasitic Drugs Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Antiparasitic Drugs Historic Market Size by Region (2018-2024)
2.2.3 Antiparasitic Drugs Forecasted Market Size by Region (2024-2034)
2.3 Antiparasitic Drugs Market Dynamics
2.3.1 Antiparasitic Drugs Industry Trends
2.3.2 Antiparasitic Drugs Market Drivers
2.3.3 Antiparasitic Drugs Market Challenges
2.3.4 Antiparasitic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiparasitic Drugs Players by Revenue
3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2018-2024)
3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiparasitic Drugs Revenue
3.4 Global Antiparasitic Drugs Market Concentration Ratio
3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2022
3.5 Antiparasitic Drugs Key Players Head office and Area Served
3.6 Key Players Antiparasitic Drugs Product Solution and Service
3.7 Date of Enter into Antiparasitic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiparasitic Drugs Breakdown Data by Type
4.1 Global Antiparasitic Drugs Historic Market Size by Type (2018-2024)
4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2024-2034)
5 Antiparasitic Drugs Breakdown Data by Application
5.1 Global Antiparasitic Drugs Historic Market Size by Application (2018-2024)
5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antiparasitic Drugs Market Size (2018-2034)
6.2 North America Antiparasitic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Antiparasitic Drugs Market Size by Country (2018-2024)
6.4 North America Antiparasitic Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiparasitic Drugs Market Size (2018-2034)
7.2 Europe Antiparasitic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Antiparasitic Drugs Market Size by Country (2018-2024)
7.4 Europe Antiparasitic Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiparasitic Drugs Market Size (2018-2034)
8.2 Asia-Pacific Antiparasitic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Antiparasitic Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Antiparasitic Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiparasitic Drugs Market Size (2018-2034)
9.2 Latin America Antiparasitic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Antiparasitic Drugs Market Size by Country (2018-2024)
9.4 Latin America Antiparasitic Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiparasitic Drugs Market Size (2018-2034)
10.2 Middle East & Africa Antiparasitic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Antiparasitic Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Antiparasitic Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ipca Laboratories Ltd
11.1.1 Ipca Laboratories Ltd Company Detail
11.1.2 Ipca Laboratories Ltd Business Overview
11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction
11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2018-2024)
11.1.5 Ipca Laboratories Ltd Recent Development
11.2 Zydus Cadila
11.2.1 Zydus Cadila Company Detail
11.2.2 Zydus Cadila Business Overview
11.2.3 Zydus Cadila Antiparasitic Drugs Introduction
11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2018-2024)
11.2.5 Zydus Cadila Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Antiparasitic Drugs Introduction
11.3.4 Merck Revenue in Antiparasitic Drugs Business (2018-2024)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiparasitic Drugs Introduction
11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2018-2024)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline Plc.
11.5.1 GlaxoSmithKline Plc. Company Detail
11.5.2 GlaxoSmithKline Plc. Business Overview
11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction
11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2018-2024)
11.5.5 GlaxoSmithKline Plc. Recent Development
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Detail
11.6.2 Cipla Ltd Business Overview
11.6.3 Cipla Ltd Antiparasitic Drugs Introduction
11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2018-2024)
11.6.5 Cipla Ltd Recent Development
11.7 Ranbaxy Laboratories
11.7.1 Ranbaxy Laboratories Company Detail
11.7.2 Ranbaxy Laboratories Business Overview
11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction
11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2018-2024)
11.7.5 Ranbaxy Laboratories Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Antiparasitic Drugs Introduction
11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2018-2024)
11.8.5 Novartis AG Recent Development
11.9 Alvizia Health Care
11.9.1 Alvizia Health Care Company Detail
11.9.2 Alvizia Health Care Business Overview
11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction
11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2018-2024)
11.9.5 Alvizia Health Care Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Detail
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Antiparasitic Drugs Introduction
11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2018-2024)
11.10.5 Bayer AG Recent Development
11.11 Roche Inc
11.11.1 Roche Inc Company Detail
11.11.2 Roche Inc Business Overview
11.11.3 Roche Inc Antiparasitic Drugs Introduction
11.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2018-2024)
11.11.5 Roche Inc Recent Development
11.12 Arbor Pharmaceuticals Inc.
11.12.1 Arbor Pharmaceuticals Inc. Company Detail
11.12.2 Arbor Pharmaceuticals Inc. Business Overview
11.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction
11.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2018-2024)
11.12.5 Arbor Pharmaceuticals Inc. Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Antiparasitic Drugs Introduction
11.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2018-2024)
11.13.5 Sanofi Recent Development
11.14 AstraZeneca
11.14.1 AstraZeneca Company Detail
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Antiparasitic Drugs Introduction
11.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2018-2024)
11.14.5 AstraZeneca Recent Development
11.15 Alkem Laboratories Limited
11.15.1 Alkem Laboratories Limited Company Detail
11.15.2 Alkem Laboratories Limited Business Overview
11.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction
11.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2018-2024)
11.15.5 Alkem Laboratories Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antiparasitic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Anthelmintics
Table 3. Key Players of Antiprotozoals
Table 4. Key Players of Others
Table 5. Global Antiparasitic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Antiparasitic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Antiparasitic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Antiparasitic Drugs Market Share by Region (2018-2024)
Table 9. Global Antiparasitic Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Antiparasitic Drugs Market Share by Region (2024-2034)
Table 11. Antiparasitic Drugs Market Trends
Table 12. Antiparasitic Drugs Market Drivers
Table 13. Antiparasitic Drugs Market Challenges
Table 14. Antiparasitic Drugs Market Restraints
Table 15. Global Antiparasitic Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Antiparasitic Drugs Market Share by Players (2018-2024)
Table 17. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitic Drugs as of 2022)
Table 18. Ranking of Global Top Antiparasitic Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Antiparasitic Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiparasitic Drugs Product Solution and Service
Table 22. Date of Enter into Antiparasitic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiparasitic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Antiparasitic Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Antiparasitic Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Antiparasitic Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Antiparasitic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Antiparasitic Drugs Revenue Market Share by Application (2018-2024)
Table 30. Global Antiparasitic Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Antiparasitic Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Antiparasitic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Antiparasitic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. Europe Antiparasitic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Antiparasitic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Antiparasitic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Asia-Pacific Antiparasitic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Antiparasitic Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Latin America Antiparasitic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Antiparasitic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Middle East & Africa Antiparasitic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Antiparasitic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Ipca Laboratories Ltd Company Detail
Table 48. Ipca Laboratories Ltd Business Overview
Table 49. Ipca Laboratories Ltd Antiparasitic Drugs Product
Table 50. Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 51. Ipca Laboratories Ltd Recent Development
Table 52. Zydus Cadila Company Detail
Table 53. Zydus Cadila Business Overview
Table 54. Zydus Cadila Antiparasitic Drugs Product
Table 55. Zydus Cadila Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 56. Zydus Cadila Recent Development
Table 57. Merck Company Detail
Table 58. Merck Business Overview
Table 59. Merck Antiparasitic Drugs Product
Table 60. Merck Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 61. Merck Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Antiparasitic Drugs Product
Table 65. Pfizer Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. GlaxoSmithKline Plc. Company Detail
Table 68. GlaxoSmithKline Plc. Business Overview
Table 69. GlaxoSmithKline Plc. Antiparasitic Drugs Product
Table 70. GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 71. GlaxoSmithKline Plc. Recent Development
Table 72. Cipla Ltd Company Detail
Table 73. Cipla Ltd Business Overview
Table 74. Cipla Ltd Antiparasitic Drugs Product
Table 75. Cipla Ltd Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 76. Cipla Ltd Recent Development
Table 77. Ranbaxy Laboratories Company Detail
Table 78. Ranbaxy Laboratories Business Overview
Table 79. Ranbaxy Laboratories Antiparasitic Drugs Product
Table 80. Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 81. Ranbaxy Laboratories Recent Development
Table 82. Novartis AG Company Detail
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Antiparasitic Drugs Product
Table 85. Novartis AG Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Alvizia Health Care Company Detail
Table 88. Alvizia Health Care Business Overview
Table 89. Alvizia Health Care Antiparasitic Drugs Product
Table 90. Alvizia Health Care Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 91. Alvizia Health Care Recent Development
Table 92. Bayer AG Company Detail
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Antiparasitic Drugs Product
Table 95. Bayer AG Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 96. Bayer AG Recent Development
Table 97. Roche Inc Company Detail
Table 98. Roche Inc Business Overview
Table 99. Roche Inc Antiparasitic Drugs Product
Table 100. Roche Inc Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 101. Roche Inc Recent Development
Table 102. Arbor Pharmaceuticals Inc. Company Detail
Table 103. Arbor Pharmaceuticals Inc. Business Overview
Table 104. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product
Table 105. Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 106. Arbor Pharmaceuticals Inc. Recent Development
Table 107. Sanofi Company Detail
Table 108. Sanofi Business Overview
Table 109. Sanofi Antiparasitic Drugs Product
Table 110. Sanofi Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 111. Sanofi Recent Development
Table 112. AstraZeneca Company Detail
Table 113. AstraZeneca Business Overview
Table 114. AstraZeneca Antiparasitic Drugs Product
Table 115. AstraZeneca Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 116. AstraZeneca Recent Development
Table 117. Alkem Laboratories Limited Company Detail
Table 118. Alkem Laboratories Limited Business Overview
Table 119. Alkem Laboratories Limited Antiparasitic Drugs Product
Table 120. Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2018-2024) & (US$ Million)
Table 121. Alkem Laboratories Limited Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiparasitic Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Antiparasitic Drugs Market Share by Type: 2022 VS 2034
Figure 3. Anthelmintics Features
Figure 4. Antiprotozoals Features
Figure 5. Others Features
Figure 6. Global Antiparasitic Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Antiparasitic Drugs Market Share by Application: 2022 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Antiparasitic Drugs Report Years Considered
Figure 12. Global Antiparasitic Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Antiparasitic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Antiparasitic Drugs Market Share by Region: 2022 VS 2034
Figure 15. Global Antiparasitic Drugs Market Share by Players in 2022
Figure 16. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitic Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2022
Figure 18. North America Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Antiparasitic Drugs Market Share by Country (2018-2034)
Figure 20. United States Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Antiparasitic Drugs Market Share by Country (2018-2034)
Figure 24. Germany Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Antiparasitic Drugs Market Share by Region (2018-2034)
Figure 32. China Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Antiparasitic Drugs Market Share by Country (2018-2034)
Figure 40. Mexico Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Antiparasitic Drugs Market Share by Country (2018-2034)
Figure 44. Turkey Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Antiparasitic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Ipca Laboratories Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 47. Zydus Cadila Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 48. Merck Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 49. Pfizer Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 50. GlaxoSmithKline Plc. Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 51. Cipla Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 52. Ranbaxy Laboratories Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 53. Novartis AG Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 54. Alvizia Health Care Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 55. Bayer AG Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 56. Roche Inc Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 57. Arbor Pharmaceuticals Inc. Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 58. Sanofi Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 59. AstraZeneca Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 60. Alkem Laboratories Limited Revenue Growth Rate in Antiparasitic Drugs Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed